Latest

Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines.

The Future of Work in Australia: Navigating Remote and Hybrid Models

Australia, Editor's Pick, Interesting Reads, Latest, Top Story

Work culture changed in Australia during the COVID-19 pandemic. Over 40% of Australians worked from home during the first half of 2021....
Read More Read More: The Future of Work in Australia: Navigating Remote and Hybrid Models

Carbonxt Group Ltd Reports Impressive Sales Growth: Activated Carbon Products Shines

Carbonxt, Editor's Pick, Latest, Most Popular, Top Stories

Carbonxt Group Limited (ASX:CG1) (“Carbonxt” or the “Company”), the leading Cleantech Company directed by Managing Director Mr...
Read More Read More: Carbonxt Group Ltd Reports Impressive Sales Growth: Activated Carbon Products Shines

VRX Silica Closes $1.5 Million Share Purchase Plan in Capital Raising Effort

Australia, Business News, Editor's Pick, Featured Business News, Latest, Most Popular, Top Stories, VRX Silica

VRX Silica Limited (ASX:VRX) (“VRX Silica” or “Company”) has concluded its Share Purchase Plan (SPP), which was initially announced...
Read More Read More: VRX Silica Closes $1.5 Million Share Purchase Plan in Capital Raising Effort

Carbonxt Appoints Nicholas Andrews as Independent Director

Australia, Business News, Carbonxt, Editor's Pick, Latest, Most Popular, SLIDER, Top Stories

Carbonxt Group LTD (ASX: CG1) (‘Carbonxt’ or ‘the Company’) appoints Mr Nicholas Andrews as the Independent Director to strengthen...
Read More Read More: Carbonxt Appoints Nicholas Andrews as Independent Director

VRX Silica Announces $3 Million Capital Raising Initiative

Australia, Business News, Latest, Most Popular, Top Stories, VRX Silica

VRX Silica Limited (ASX: VRX) (VRX Silica or Company), an advanced pureplay silica sand company led by MD Bruce Maluish, has announced a...
Read More Read More: VRX Silica Announces $3 Million Capital Raising Initiative
Close Search Window
Close